Clover Health Investments Corp (NASDAQ: CLOV) kicked off on Monday, down -2.35% from the previous trading day, before settling in for the closing price of $3.41. Over the past 52 weeks, CLOV has traded in a range of $0.61-$4.71.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 52.25%. While this was happening, its average annual earnings per share was recorded 73.31%. With a float of $372.95 million, this company’s outstanding shares have now reached $393.27 million.
Let’s determine the extent of company efficiency that accounts for 552 employees. In terms of profitability, gross margin is 33.96%, operating margin of -5.84%, and the pretax margin is -6.21%.
Clover Health Investments Corp (CLOV) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Healthcare Plans Industry. The insider ownership of Clover Health Investments Corp is 24.94%, while institutional ownership is 15.46%. The most recent insider transaction that took place on Aug 09 ’24, was worth 999,596. In this transaction Director of this company bought 531,700 shares at a rate of $1.88, taking the stock ownership to the 1,409,267 shares. Before that another transaction happened on Jun 17 ’24, when Company’s Director bought 877,567 for $1.14, making the entire transaction worth $1,000,426. This insider now owns 877,567 shares in total.
Clover Health Investments Corp (CLOV) Earnings and Forecasts
In the latest quarterly report, which was put into the public domain on 9/30/2024, the organization reported -0.14 earnings per share (EPS), higher than consensus estimate (set at -0.14) by 0. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.04 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 73.31% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 19.10% during the next five years compared to -585.84% drop over the previous five years of trading.
Clover Health Investments Corp (NASDAQ: CLOV) Trading Performance Indicators
Take a look at Clover Health Investments Corp’s (CLOV) current performance indicators. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.00.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.19, a number that is poised to hit -0.07 in the next quarter and is forecasted to reach -0.14 in one year’s time.
Technical Analysis of Clover Health Investments Corp (CLOV)
Looking closely at Clover Health Investments Corp (NASDAQ: CLOV), its last 5-days average volume was 13.34 million, which is a jump from its year-to-date volume of 8.11 million. As of the previous 9 days, the stock’s Stochastic %D was 12.15%. Additionally, its Average True Range was 0.30.
During the past 100 days, Clover Health Investments Corp’s (CLOV) raw stochastic average was set at 61.45%, which indicates a significant increase from 8.24% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 82.39% in the past 14 days, which was lower than the 99.86% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.48, while its 200-day Moving Average is $1.80. However, in the short run, Clover Health Investments Corp’s stock first resistance to watch stands at $3.41. Second resistance stands at $3.49. The third major resistance level sits at $3.59. If the price goes on to break the first support level at $3.24, it is likely to go to the next support level at $3.14. Should the price break the second support level, the third support level stands at $3.06.
Clover Health Investments Corp (NASDAQ: CLOV) Key Stats
The company with the Market Capitalisation of 1.54 billion has total of 497,469K Shares Outstanding. Its annual sales at the moment are 2,034 M in contrast with the sum of -213,360 K annual income. Company’s last quarter sales were recorded 356,260 K and last quarter income was 7,410 K.
